Proteus Digital Health developed digital medicines including ingestible sensors embedded in pharmaceutical tablets and wearable patches that detect medication adherence and monitor physiological response. The company pioneered sensor-enabled drug delivery technology combined with cloud-based data analytics for patient monitoring.
Proteus Digital Health has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2003
Total Funding
$322.5M
9 rounds
Total raised $322.5M across 9 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Last updated 06-25-2026
Latest Round
Type
Series H
Date
October 11, 2018
Amount
$88M
Valuation
—
Lead Investors
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| October 11, 2018 | Series H | $88M | — | Otsuka Pharmaceutical |
| July 29, 2014 | Series G (second close) | $52M | — | Not disclosed |
| June 2, 2014 | Series G (initial close) | $120M | — | Not disclosed |
Andrew Thompson
Co-Founder and Chief Executive Officer
George Savage
Co-Founder
Mark Zdeblick
Co-Founder
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Medication Adherence Technologies
Companies offering digital health and adherence monitoring solutions
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.